Extrovis` Sugammadex Receives Approval in Europe
Extrovis` Lacosamide Adroiq (lacosamide) Receives Approval in Europe
Megasoft completed the acquisition of 40% stake in Extrovis AG.
Megasoft Limited agreed to acquire 40% stake in EXTROVIS AG for $16 million.